Summary
Dr. Paul Newhouse, a physician and neuroscientist at Vanderbilt University who has studied the brain's cholinergic system for over 40 years, joins Liz Moody to discuss the therapeutic potential of nicotine when separated from tobacco. Newhouse explains that nicotine mimics the neurotransmitter acetylcholine at nicotinic receptors, acting as a modulator that can amplify or dampen brain activity depending on context -- calming you when agitated, sharpening you when sluggish. He calls it "the perfect psychotropic drug" for this reason. The conversation covers Newhouse's ongoing MIND trial, which has been giving nicotine patches to non-smokers with memory loss for up to two years since 2018 and will produce the longest safety database of non-smoker nicotine use ever published. He reports that transdermal nicotine via patches does not appear to be addictive, with subjects stopping abruptly with no withdrawal or cravings. They discuss nicotine's potential benefits for Alzheimer's, ADHD, depression, long COVID brain fog, appetite suppression, and emotional regulation, as well as its lack of carcinogenicity on its own. Newhouse emphasizes that nicotine is not the same as tobacco, noting "nicotine is a good drug, but tobacco is a bad delivery system," and recommends starting at low doses (7-10mg patches) under medical supervision.
Key Points
- Nicotine mimics acetylcholine at nicotinic receptors, modulating brain circuits by amplifying or dampening activity depending on your current state
- Transdermal nicotine (patches) does not appear to be addictive -- subjects in clinical trials stop abruptly with no withdrawal, cravings, or side effects
- The MIND trial at Vanderbilt has given nicotine patches to non-smokers with memory loss for up to 2 years, producing the longest safety database of non-smoker nicotine use
- Nicotine by itself is not carcinogenic and appears reasonably safe at therapeutic doses, though tobacco contains thousands of harmful compounds
- Preliminary data shows nicotine improves executive function in ADHD and produces rapid mood improvement in late-life depression at doses of 7-10mg per day
- In clinical trials, nicotine patch users lost about 5 pounds over 3 months through appetite suppression, though the effect plateaus
- Nicotine is not beneficial for sleep -- the cholinergic system is an alerting system, and nicotine patches should not be worn close to bedtime
- Nicotine increases the number of nicotinic receptors in the brain over time (upregulation), which is the opposite of most stimulant drugs
Key Moments
Nicotine as a brain modulator -- calming when agitated, alerting when calm
Dr. Newhouse explains that nicotine acts as a bidirectional modulator of brain systems, dampening activity when you're anxious and amplifying it when you need alertness. He calls it "the perfect psychotropic drug" because it helps the brain maintain balance.
"And so I think that's why I've called it in the past the perfect psychotropic drug. It makes you calm when you're agitated, and it can make you a little bit more agitated if you're too calm."
Nicotine patches are not addictive in non-smokers
Newhouse reveals that nicotine by itself does not appear to be addictive when delivered slowly via transdermal patches. In his clinical trials, subjects stopped abruptly with no withdrawal, cravings, or side effects. The addiction risk depends on speed and route of administration.
"It turns out that nicotine by itself doesn't appear to be very addictive."
Nicotine improves attention and memory in Alzheimer's patients
Newhouse discusses 40 years of research showing nicotine can improve attention and memory in patients with memory loss. While it may not block the molecular damage causing Alzheimer's, it enhances the cholinergic system's ability to resist the effects of that damage, essentially pushing symptoms back.
"I think there's evidence that nicotine can produce improvements in attention and memory for some patients with memory loss."
Nicotine shows dramatic results for depression via executive function enhancement
Newhouse describes preliminary findings showing nicotine produces rapid mood improvement in late-life depression patients by enhancing executive function -- the ability to plan, manage attention, and regulate cognitive processes. This same mechanism explains why it helps ADHD. Lower doses of 7-10mg appear more effective than the highest 21mg patches.
"We found a dramatic effect in terms of rapid improvement of mood. We're very excited about this."
Nicotine is not carcinogenic and the biggest misconception is confusing it with tobacco
Newhouse states definitively that nicotine by itself is not carcinogenic and challenges anyone to show that nicotine alone is addictive. He argues the biggest misconception is failing to separate nicotine from tobacco, coining the phrase "nicotine is a good drug, but tobacco is a bad delivery system."
"So there's really no evidence that nicotine by itself is carcinogenic."
